Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)
Titel:
Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)
Auteur:
Horn, L. Whisenant, J.G. Wakelee, H. Reckamp, K.L. Qiao, H. Du, L. Hernandez, J. Huang, V. Waqar, S.N. Patel, S. Sanborn, R.E. Shaffer, T. Garg, K. Holzhausen, A. Harrow, K. Liang, C. Lim, L.P. Li, M. Lovly, C.M.